ArticleThe Journal of clinical investigation2024

Off-target autophagy inhibition by SHP2 allosteric inhibitors contributes to their antitumor activity in RAS-driven cancers.

Yiming Miao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.